BRPI0910775A2 - compostos 1,5-difenil pirrolidin-2-ona como ligantes cb-1 - Google Patents

compostos 1,5-difenil pirrolidin-2-ona como ligantes cb-1

Info

Publication number
BRPI0910775A2
BRPI0910775A2 BRPI0910775A BRPI0910775A BRPI0910775A2 BR PI0910775 A2 BRPI0910775 A2 BR PI0910775A2 BR PI0910775 A BRPI0910775 A BR PI0910775A BR PI0910775 A BRPI0910775 A BR PI0910775A BR PI0910775 A2 BRPI0910775 A2 BR PI0910775A2
Authority
BR
Brazil
Prior art keywords
pyrrolidin
ligands
diphenyl
compounds
diphenyl pyrrolidin
Prior art date
Application number
BRPI0910775A
Other languages
English (en)
Inventor
John Mehnert Schaus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BRPI0910775A2 publication Critical patent/BRPI0910775A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
BRPI0910775A 2008-04-22 2009-04-02 compostos 1,5-difenil pirrolidin-2-ona como ligantes cb-1 BRPI0910775A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4694308P 2008-04-22 2008-04-22
PCT/US2009/039293 WO2009131815A1 (en) 2008-04-22 2009-04-02 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands

Publications (1)

Publication Number Publication Date
BRPI0910775A2 true BRPI0910775A2 (pt) 2015-09-29

Family

ID=40600096

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910775A BRPI0910775A2 (pt) 2008-04-22 2009-04-02 compostos 1,5-difenil pirrolidin-2-ona como ligantes cb-1

Country Status (17)

Country Link
US (1) US8420654B2 (pt)
EP (1) EP2280961B1 (pt)
JP (1) JP5539323B2 (pt)
KR (1) KR101283803B1 (pt)
CN (1) CN102007121B (pt)
AU (1) AU2009238445B2 (pt)
BR (1) BRPI0910775A2 (pt)
CA (1) CA2721542C (pt)
DK (1) DK2280961T3 (pt)
EA (1) EA019067B1 (pt)
ES (1) ES2390560T3 (pt)
HR (1) HRP20120680T1 (pt)
MX (1) MX2010011547A (pt)
PL (1) PL2280961T3 (pt)
PT (1) PT2280961E (pt)
SI (1) SI2280961T1 (pt)
WO (1) WO2009131815A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3813152B2 (ja) * 2002-03-12 2006-08-23 メルク エンド カムパニー インコーポレーテッド 置換アミド類
TW200533657A (en) 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
HRP20080689T3 (hr) * 2004-02-19 2009-05-31 Solvay Pharmaceuticals B.V. Imidazolinski derivati sa cb1-antagonističkom aktivnosti
WO2007020502A2 (en) * 2005-08-16 2007-02-22 Pharmacia & Upjohn Company Llc Cannabinoid receptor ligands and uses thereof
WO2008039023A1 (en) * 2006-09-29 2008-04-03 Green Cross Corporation Heteroaryl-pyrazole derivatives as cannabinoid cb1 receptor antagonists
TW200825067A (en) * 2006-10-23 2008-06-16 Lilly Co Eli CB1 compounds

Also Published As

Publication number Publication date
EP2280961B1 (en) 2012-07-25
US8420654B2 (en) 2013-04-16
HRP20120680T1 (hr) 2012-10-31
EP2280961A1 (en) 2011-02-09
KR101283803B1 (ko) 2013-07-15
PT2280961E (pt) 2012-09-10
MX2010011547A (es) 2010-11-09
EA201071223A1 (ru) 2011-04-29
WO2009131815A1 (en) 2009-10-29
AU2009238445B2 (en) 2013-09-26
US20110034484A1 (en) 2011-02-10
CA2721542A1 (en) 2009-10-29
DK2280961T3 (da) 2012-08-27
PL2280961T3 (pl) 2012-12-31
KR20100124342A (ko) 2010-11-26
JP2011518220A (ja) 2011-06-23
SI2280961T1 (sl) 2012-11-30
CN102007121A (zh) 2011-04-06
EA019067B1 (ru) 2013-12-30
CA2721542C (en) 2016-03-29
AU2009238445A1 (en) 2009-10-29
CN102007121B (zh) 2013-08-14
ES2390560T3 (es) 2012-11-14
JP5539323B2 (ja) 2014-07-02

Similar Documents

Publication Publication Date Title
BRPI0911542A2 (pt) compostos de quinuclina como ligantes de receptor de receptor de acetilcolina alfa-7-nicotínica
CR10926A (es) Nuevas 2-aminooxazolinas como ligandos taar1
DK2288375T3 (da) Pegylerede insulin-lispro-forbindelser
BRPI0815067A2 (pt) Compostos de biciclotactama substituída
BRPI0920707A2 (pt) compostos
SMT201500117B (it) Composti antibatterici
DK2242759T3 (da) Forbindelser
BRPI0815042A2 (pt) Compostos de pirazol
EP2302180A4 (en) CONSTRUCTION MACHINE
BRPI0810250A2 (pt) Compostos inéditos
SMT201600045B (it) Composti tetraciclinici c7-fluoro sostituiti
BRPI0919135A2 (pt) compostos inéditos como ligantes do receptor canabinóide.
DK2297162T3 (da) Forbindelser
BRPI0814565A2 (pt) Máquina hidráulica
DK2348809T3 (da) Balleindpakningsmaskine
EP2246570A4 (en) TURBOMACHINE
EP2317017A4 (en) CONSTRUCTION MACHINE
BRPI0914446A2 (pt) complexo de organoborano
BRPI0916432A2 (pt) compostos
EP2268635A4 (en) HETEROCYCLIC COMPOUNDS
BRPI0909467A2 (pt) máquina de compactação
DK2206698T3 (da) Ethynylindolforbindelser
BRPI0916395A2 (pt) compostos de 1,6-di-hidro-2h-3-oxa-6-aza-as-indaceno
PT2792662T (pt) Compostos de morfinano
BRPI0922152A2 (pt) Compostos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.